Clinical trial
Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated…
NCT00496821 · Alnylam Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00496821 |
|---|---|
| Title | Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus |
| Official title | A Study to Investigate the Safety and Efficacy of Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus |
| Lead sponsor | Alnylam Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Respiratory Syncytial Virus Infections |
| Intervention type | Drug |
| Interventions | ALN-RSV01 |
| Enrollment | 88 |
| Start date | Jul 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jul 4, 2007 |
| Last update posted | Nov 30, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: